FoLix by Lumenis is the first nonablative fractional laser to be FDA cleared as a hair loss treatment.
It works by delivering laser energy into the scalp’s dermal layer, without damaging the surface. Controlled heat triggers a natural healing response that boosts blood flow and activates cytokine activity and promotes collagen synthesis (new collagen formation), to stimulate hair follicles.
In the weeks post-treatment, you should start to notice new hair growth and a healthier look to the hair you already had.
Clinical studies by Lumenis show an increase in the number of hairs and an improvement in hair appearance, with minimal discomfort: 1–2.5 on a scale of 10 (with 10 being the worst possible pain).
Board-certified plastic surgeon Dr. Goretti Ho Taghva offers FoLix at the LEA Aesthetics Lab, her practice in Newport Beach, California. She says they’ve had “very positive feedback from patients undergoing FoLix treatments. The majority begin to notice new hair growth after 3 to 4 monthly sessions, with optimal results typically seen after a series of 6. Because it’s a newer technology, some patients start conservatively with 4 treatments—but visible results often motivate them to complete the full series.”
As Dr. Ho Taghva explains, “what makes FoLix especially exciting is that, unlike topical treatments like minoxidil that require ongoing daily use to maintain results, FoLix stimulates natural follicular regrowth by triggering a healing response. It increases blood flow, enhances oxygen and nutrient delivery to the scalp, and activates cytokine signaling to reawaken dormant follicles. The effect is regenerative, not just maintenance-based.”
How does it compare to other nonsurgical options? Dr. Ho Taghva says her practice “offered PRP injections in the past with some success, but we did not see the same level of consistent responses we see when compared to FoLix. PRP injections are also a lot more painful,” which is why her practice no longer offers them.
This relatively new treatment option is becoming more widely available across the U.S., Canada, Hong Kong, and the Middle East.
